Marshall Wace, LLP Isoray, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Isoray, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 18,971,733 shares of ISR stock, worth $13.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,971,733Holding current value
$13.1 Million% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding ISR
# of Institutions
102Shares Held
248MCall Options Held
0Put Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY28.2MShares$19.4 Million0.4% of portfolio
-
Commodore Capital LP New York, NY21.1MShares$14.5 Million1.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.8MShares$12.3 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY14.7MShares$10.2 Million1.59% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.5MShares$9.28 Million0.02% of portfolio
About Isoray, Inc.
- Ticker ISR
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 142,112,992
- Market Cap $98.1M
- Description
- Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...